Search

Your search keyword '"Duygu Ersözlü"' showing total 5 results
Start Over Author "Duygu Ersözlü" Publisher aves
5 results on '"Duygu Ersözlü"'

1. The First Effect of COVID-19 Pandemic on Starting Biological Disease Modifying Anti-Rheumatic Drugs: Outcomes from the TReasure Real-Life Database

Author

Nilüfer Alpay Kanıtez, Sedat Kiraz, Ediz Dalkılıç, Gezmiş Kimyon, Rıdvan Mercan, Ömer Karadağ, Cemal Bes, Levent Kılıç, Servet Akar, Aşkın Ateş, Hakan Emmungil, İhsan Ertenli, Yavuz Pehlivan, Belkıs Nihan Coşkun, Burcu Yağız, Duygu Ersözlü, Emel Gönüllü, Muhammet Çınar, Timuçin Kaşifoğlu, Süleyman Serdar Koca, Uğur Karasu, Orhan Küçükşahin, and Umut Kalyoncu

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2022
Full Text
View/download PDF

2. Exon 2: Is it the good police in familial mediterranean fever?

Author

Şule Yaşar Bilge, Dilek Solmaz, Soner Şenel, Hakan Emmungil, Levent Kılıç, Sibel Yılmaz Öner, Fatih Yıldız, Sedat Yılmaz, Duygu Ersözlü Bozkırlı, Müge Aydın Tufan, Sema Yılmaz, Veli Yazısız, Yavuz Pehlivan, Cemal Beş, Gözde Yıldırım Çetin, Şükran Erten, Emel Gönüllü, Fezan Şahin, Servet Akar, Kenan Aksu, Umut Kalyoncu, Haner Direskeneli, Eren Erken, Bünyamın Kısacık, Mehmet Sayarlıoğlu, Muhammed Çınar, Timuçin Kaşifoğlu, and İsmail Sarı

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2019
Full Text
View/download PDF

3. Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry

Author

Sibel Zehra Aydın, Gezmiş Kimyon, Cem Özişler, Emine Figen Tarhan, Esen Kasapoğlu Günal, Adem Küçük, Ahmet Omma, Dilek Solmaz, Emine Duygu Ersözlü, Fatih Yıldız, Müge Aydın Tufan, Muhammet Çınar, Rıdvan Mercan, Şule Yavuz, Fatıma Arslan Alhussain, Abdulsamet Erden, Meryem Can, Gözde Yıldırım Çetin, Levent Kılıç, Sibel Bakırcı, Noura Al Osaimi, and Umut Kalyoncu

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2020
Full Text
View/download PDF

4. Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry

Author

Abdulsamet Erden, Esen Kasapoglu Gunal, Sibel Zehra Aydin, Cem Ozisler, Ahmet Omma, Sibel Bakirci, Müge Aydın Tufan, Meryem Can, Noura Al Osaimi, Rıdvan Mercan, Dilek Solmaz, Umut Kalyoncu, Emine Figen Tarhan, Emine Duygu Ersözlü, Gozde Yildirim Cetin, Fatıma Arslan Alhussain, Sule Yavuz, Levent Kilic, Gezmiş Kimyon, Fatih Yildiz, Adem Kucuk, Muhammet Cinar, and MÜ

Subjects
Body surface area, lcsh:Immunologic diseases. Allergy, medicine.medical_specialty, business.industry, psoriasis, registry, medicine.disease, Real life data, Rheumatology, Validity, Psoriatic arthritis, International database, Internal medicine, Psoriasis, Brodalumab, medicine, Original Article, Patient-reported outcome, business, lcsh:RC581-607, Signs, disease activity
Abstract

Yildiz, Fatih/0000-0003-3628-8870; Cinar, Muhammet/0000-0002-6150-3539 WOS: 000537230800003 PubMed ID: 31922480 Objective: Our aim is to test the validity of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome, to assess the psoriasis severity within the scope of rheumatology. Methods: Within the PsA international database (PSART-ID), 571 patients had PSI, while 322 of these also showed body surface area (BSA). Correlations between PSI, BSA, and other patient- and physician-reported outcomes were investigated. Results: There was a good correlation between PSI and BSA (r=0.546, p

Published
2020

5. Exon 2: Is it the good police in familial mediterranean fever?

Author

Bilge ŞY, Solmaz D, Şenel S, Emmungil H, Kılıç L, Öner SY, Yıldız F, Yılmaz S, Bozkırlı DE, Tufan MA, Yılmaz S, Yazısız V, Pehlivan Y, Beş C, Çetin GY, Erten Ş, Gönüllü E, Şahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kısacık B, Sayarlıoğlu M, Çınar M, Kaşifoğlu T, and Sarı İ

Abstract

Objective: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease. Most of the identified disease-causing mutations are located on exon 10. As the number of studies about the effect of the exonal location of the mutation and its phenotypic expression is limited, we aimed to investigate whether the exonic location of the Mediterranean fever (MEFV) mutation has an effect on the clinical manifestation in patients with FMF., Methods: Study population was derived from the main FMF registry that included 2246 patients from 15 different rheumatology clinics. We categorized the mutations according to their exon locations and retrieved the clinical and demographic information from the database., Results: Patients having the MEFV mutations on exon 2 or 10 (n:1526) were divided into three subgroups according to the location of the MEFV mutations: Group 1 (exon 2 mutations), Group 2 (exon 10 mutations), and Group 3 (both exon 2 and exon 10 mutations). Group 2 patients were of a significantly younger age at onset, and erysipel-like erythema, arthritis, amyloidosis, and a family history of FMF were more common in this group., Conclusion: Patients with FMF and exon 10 mutations show more severe clinical symptoms and outcome. Exon 2 mutations tend to have a better outcome.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results